TD Asset Management
TNGX icon

TD Asset Management’s Tango Therapeutics TNGX Stock Holding History

TD Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.15M Buy
+102,600
New +$1.43M ﹤0.01% 950
2025
Q4 		– Sell
-18,072
Closed -$152K – 1297
2025
Q3 		$152K Buy
+18,072
New +$122K ﹤0.01% 1229
2024
Q4 		– Sell
-79,978
Closed -$597K – 1400
2024
Q3 		$597K Buy
79,978
+20,200
+34% +$193K ﹤0.01% 1276
2024
Q2 		$513K Hold
59,778
– – ﹤0.01% 1273
2024
Q1 		$475K Buy
+59,778
New +$641K ﹤0.01% 1308

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

TD Asset Management's TNGX Position: Q1 2026 in Review

TD Asset Management opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 102,600 shares worth $2.15M. The stake represents ﹤0.01% of the portfolio and ranks #950 among its holdings. This is a return to the name: TD Asset Management previously reported a position in TNGX as recently as Q3 2025.

TD Asset Management first reported a position in TNGX in Q1 2024 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • TD Asset Management held 102,600 shares of Tango Therapeutics worth $2.15M as of Q1 2026.
  • Tango Therapeutics was a new TD Asset Management position in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #950 holding.
  • TD Asset Management first reported a position in Tango Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.